Report forecast the global venturi masks
market to grow at a CAGR of 16.46% during the period 2017-2021.
A venturi mask or an air-entrainment mask
is a medical device that delivers a known oxygen concentration to patients on
controlled oxygen therapy. It can deliver oxygen concentrations ranging from
24% to 80% with flow rates of 4-12 L/min. The major clinical applications of
venturi masks include COPD and asthma. The other applications include
respiratory distress syndrome, cystic fibrosis (CF), pneumonia, acute
myocardial infarction, severe trauma, and neuromuscular diseases causing
ventilatory failure.
The report covers the present scenario and
the growth prospects of the global venturi masks market for 2017-2021. The
report presents a detailed picture of the market by way of study, synthesis,
and summation of data from multiple sources.
The
market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
According to the report, one driver in the
market is increasing prevalence of chronic respiratory disorders. The
healthcare industry has witnessed a paradigm shift from hospital care to
homecare over the last decade. This trend is especially evident among the older
population and people with chronic diseases. Technological advances and
improvement in healthcare services are influencing many people to access
home-based medical care to improve patient outcome and reduce healthcare
expenditure. The availability of venturi masks with improved designs that are
easy to use, combining comfort and efficiency, is increasing patient's
preference for homecare to reduce the burden of high cost and lengthy hospital
stays.
Further, the report states that one
challenge in the market is unfavorable reimbursement scenario. Declining
reimbursement and unfavorable shifts in the payer mix significantly impact the
treatment of chronic disease conditions. Chronic respiratory disorders such as
COPD, asthma, and pneumonia require long-term oxygen therapy. The Medicare
reimbursement for home-based oxygen therapy in the US is limited to 36 months
due to Deficit Reduction Act of 2005 (DRA). It prevents oxygen providers to
receive reimbursement coverage for costs related to treatment beyond 36 months.
Global
Venturi Masks Market 2017-2021, has been prepared
based on an in-depth market analysis with inputs from industry experts. The
report covers the market landscape and its growth prospects over the coming
years. The report also includes a discussion of the key vendors operating in
this market.
key players in the global venturi masks
market: BD, Besmed Health Business, Flexicare Medical, Smiths Medical, and
Salter Labs.
Other Prominent Vendors in the market are:
DEAS, For Care Enterprise, Intersurgical, Sure Care, and Tylenol Medical
Instrument.
Market
driver
- Increasing prevalence of chronic respiratory disorders
- For a full, detailed list, view our report
Market
challenge
- Unfavorable reimbursement scenario
- For a full, detailed list, view our report
Market
trend
- Increasing focus on improved product designs
- For a full, detailed list, view our report
Key
questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
Spanning over 72 pages “Global
Venturi Masks Market 2017 - 2021” report covers Executive summary, Introduction,
Scope of the report, Research Methodology, Market landscape, Geographical
segmentation, Market segmentation by application, Market segmentation by
end-users, Decision framework, Drivers and challenges, Market trends, Vendor
landscape, Key vendor analysis, Appendix.
Please visit this link for more details: http://mrr.cm/Uqb
For related reports please visit: Mask Market Research Reports
Find all Pharma
and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.